You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

Dermatology

A Tale of Two Itches: Bridging the Gap With Type 2 Inflammation in PN and CSU

Join Drs. Elmariah, Kim, and Metz as they explore the latest research on neuro-immune mechanisms driving chronic itch and inflammation in PN and CSU.

MD, PhD

Sarina Elmariah +2 more

See post-event materials

A Tale of Two Itches: Bridging the Gap With Type 2 Inflammation in PN and CSU

Past event

11March2024

Location

Hilton San Diego Bayfront

1 Park Blvd San Diego, California 92101 USA

Learning objectives

Understand the shared underlying pathomechanism manifesting in chronic signs and symptoms of two very distinct disease
Recall the latest research on itch pathophysiology and the neuro-immune mechanisms that drive the unique disease characteristics of PN and CSU

Description

Join the ADVENT program in San Diego for an educational symposium with Drs. Sarina Elmariah, Brian Kim, and Martin Metz, who will explore the latest research on neuro-immune mechanisms driving chronic itch and inflammation in PN and CSU.

*This program does not qualify for Continuing Medical Education (CME) credit and is not part of the official AAD Annual Meeting as planned or endorsed by its Scientific Assembly Committee

Location

Hilton San Diego Bayfront

1 Park Blvd San Diego, California 92101 USA

Speakers

Dermatology

MD, PhD

Sarina Elmariah

Associate Professor and Dermatology Director at the UCSF Centre for Itch and Neurosensory Disorders at the University of California in San Francisco, California, US

Dermatology

Brian Kim

Professor, Vice Chair of Research, and Site Chair of Mount Sinai West, Icahn School of Medicine, NY, US

Allergy/Immunology

Martin Metz

Professor in the Department of Dermatology and Allergy, Head of Translational Research, and Deputy Head of Clinical Trials | Charité – Universitätsmedizin, Berlin, Germany

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region